首页|低剂量艾司氯胺酮复合丙泊酚在无痛结肠镜检查中的麻醉效果观察

低剂量艾司氯胺酮复合丙泊酚在无痛结肠镜检查中的麻醉效果观察

扫码查看
目的 观察低剂量艾司氯胺酮复合丙泊酚在无痛结肠镜检查中的麻醉效果。方法 68 例行无痛结肠镜检查的门诊患者,按随机数字表法分为观察组和对照组,各 34 例。观察组给予低剂量艾司氯胺酮+丙泊酚进行麻醉,对照组单纯使用丙泊酚进行麻醉。比较两组患者不同时间点[麻醉前(T1)、进肠镜时(T2)、肠镜至脾曲时(T3)、肠镜至肝曲时(T4)、肠镜至回盲瓣时(T5)]生命体征[平均动脉压(MAP)、心率(HR)、血氧饱和度(SpO2)]、麻醉相关指标(麻醉起效时间、苏醒时间、丙泊酚总用量、明显体动反应情况)、镇静镇痛效果及不良事件发生情况。结果 T1 时,两组MAP、HR、SpO2比较,差异无统计学意义(P>0。05);T2、T3、T4、T5 时,两组MAP、HR、SpO2 均低于T1 时,但观察组MAP、HR、SpO2 均高于对照组,差异有统计学意义(P<0。05)。观察组麻醉起效时间(19。38±3。23)s、苏醒时间(7。92±1。41)min均短于对照组的(30。74±3。60)s、(12。41±1。38)min,丙泊酚总用量(106。00±16。05)mg少于对照组的(147。44±18。34)mg,明显体动反应占比 35。3%低于对照组的 67。6%,差异有统计学意义(P<0。05)。观察组镇静镇痛优良率64。7%高于对照组的32。4%,差异有统计学意义(P<0。05)。观察组注射疼痛、循环抑制、呼吸抑制、心动过缓发生率分别为 17。6%、11。8%、14。7%、8。8%,均明显低于对照组的 55。9%、38。2%、44。1%、35。3%,差异有统计学意义(P<0。05);两组恶心呕吐发生率比较,差异无统计学意义(P>0。05)。结论 低剂量艾司氯胺酮复合丙泊酚用于无痛结肠镜检查中镇静镇痛效果理想,相较单纯使用丙泊酚,患者的生命体征更稳定,更安全。
Observation on anesthesia effect of low-dose esketamine compounded with propofol in painless colonoscopy
Objective To observe the anesthesia effect of low-dose esketamine compounded with propofol in painless colonoscopy.Methods 68 outpatients who underwent painless colonoscopy were divided into an observation group and a control group according to random numerical table,with 34 cases in each group.The observation group was given low dose esketamine + propofol for anesthesia,and the control group was given propofol only for anesthesia.Comparison was made on vital signs[mean arterial pressure(MAP),heart rate(HR),and oxygen saturation(SpO2)]at different time points[before anesthesia(T1),at the time of enteroscopy(T2),during enteroscopy to the splenic flexure(T3),during enteroscopy to the hepatic flexure(T4),and during enteroscopy to the ileocecal valve(T5)],anesthesian-related indicators(onset of anesthesia,time to awakening,total propofol dosage,apparent body movement),sedative and analgesic effect,and occurrence of adverse events.Results At T1,there was no statistically significant difference in MAP,HR and SpO2 between the two groups(P>0.05).At T2,T3,T4 and T5,MAP,HR and SpO2 in both groups were lower than those at T1,but MAP,HR and SpO2 in the observation group were higher than those in the control group,and the difference was statistically significant(P<0.05).The onset of anesthesia of(19.38±3.23)s and time to awakening of(7.92±1.41)min in the observation group were shorter than those of(30.74±3.60)s and(12.41±1.38)min in the control group;the total propofol dosage of(106.00±16.05)mg in the observation group was lower than that of(147.44±18.34)mg in the control group;the proportion of apparent body movement of 35.3%in the observation group was lower than that of 67.6%in the control group;the differences were statistically significant(P<0.05).The excellent rate of sedation and analgesia in the observation group was 64.7%,which was higher than that of 32.4%in the control group,the difference was statistically significant(P<0.05).The incidence rates of injection pain,circulatory depression,respiratory depression and bradycardia in the observation group were 17.6%,11.8%,14.7%and 8.8%,which were significantly lower than those of 55.9%,38.2%,44.1%and 35.3%in the control group,and the difference was statistically significant(P<0.05).There was no statistically significant difference in the incidence of nausea and vomiting between the two groups(P>0.05).Conclusion The combination of low-dose esketamine and propofol provides ideal effect of sedation and analgesia in painless colonoscopy.Compared with propofol alone,patients'vital signs are more stable and safer.

EsketaminePropofolPainless colonoscopySedationAnalgesia

濮颖秋、王政、刘颖

展开 >

212400 江苏大学附属句容医院麻醉科

艾司氯胺酮 丙泊酚 无痛结肠镜 镇静 镇痛

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(1)
  • 22